We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04816643
Brief Title: A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults

First Submitted : March 19, 2021
First Submitted that Met QC Criteria : March 24, 2021
First Posted : March 25, 2021

Last Update Submitted that Met QC Criteria : January 23, 2023
Last Update Posted : January 25, 2023